Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;52(7):790-795.
doi: 10.1016/j.pathol.2020.09.006. Epub 2020 Sep 30.

Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent

Alexa M Kaufer  1 , Torsten Theis  2 , Katherine A Lau  2 , Joanna L Gray  2 , William D Rawlinson  3
Affiliations

Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent

Alexa M Kaufer et al. Pathology. 2020 Dec.

Abstract

The current public health emergency surrounding the COVID-19 pandemic, that is the illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in thousands of cases in Australia since 25 January 2020 when the first case was diagnosed. This emerging virus presents particular hazards to researchers and laboratory staff in a clinical setting, highlighted by rapid and widespread global transmission. Based on the epidemiological and clinical data that have become available in mid-2020, we propose the interim classification of SARS-CoV-2 as a Risk Group 3 organism is reasonable, and discuss establishing Biosafety Level 3 (BSL-3) regulations accordingly. Despite its global spread, the reported mortality rate of SARS-CoV-2 ranging from 0.13% to 6.22% is considerably less than that of other Risk Group 4 agents including Ebola and Marburg viruses with fatality rates as high as 90%. In addition, studies have demonstrated that approximately 86% of patients presenting with severe courses of the disease are aged 70 years or above, with the presence of comorbid conditions such as cardiovascular and respiratory system diseases in the majority of all fatal cases. In contrary to recent discussions surrounding the protective and administrative measures needed in a laboratory, the emerging evidence surrounding mortality rate, distinct demographics of severe infections, and the presence of underlying diseases does not justify the categorisation of SARS-CoV-2 as a Risk Group 4 organism. This article summarises biosafety precautions, control measures and appropriate physical containment facilities required to minimise the risk of laboratory-acquired infections with SARS-CoV-2.

Keywords: COVID-19; SARS-CoV; SARS-CoV-2; biosafety level; physical containment; risk group.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Chart demonstrating how the Risk Group of an organism should help determine the biosafety level that is required for the safe handling of the agent, and identify the physical containment facilities that should be used.
See this image and copyright information in PMC

References

    1. Caly L., Druce J., Roberts J., et al. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med J Aust. 2020;212:459–462. - PMC - PubMed
    1. Lippi G., Adeli K., Ferrari M., et al. Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations. Clin Chem Lab Med. 2020;58:1053–1062. - PubMed
    1. Gorbalenya A.E., Baker S.C., Baric R.S., et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–544. - PMC - PubMed
    1. Payne S. In: Viruses. Payne S., editor. Academic Press; Cambridge: 2017. Family Coronaviridae; pp. 149–158.
    1. Hasöksüz M., Kiliç S., Saraç F. Coronaviruses and SARS-COV-2. Turk J Med Sci. 2020;50:549–556. - PMC - PubMed